Agrynex
Ithaca
About Agrynex
Agrynex delivers biocidal enzymes to protect the crop against soil-borne diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $50.0K
- Last round: Grant (Apr 2023)
- Website: agrynex.us
- Phone: [email protected]
Industries & Categories
Agriculture, Biotechnology, Chemical, Health Care
Social Profiles
Canonical: https://fsome.com/organization/agrynex-174178 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.